Microencapsulated vaccines to provide prolonged immunity with a single administration

Area of Science:

• Biotechnology
• Immunology
• Materials Science

Background:

• Single-administration vaccines reduce costs and improve compliance in immunization programs.
• Biodegradable polymer microspheres are being developed for controlled, timed antigen release.
• Poly-DL-lactide-co-glycolide (PLGA) microspheres offer tunable biodegradation rates.

Purpose of the Study:

• To develop and evaluate a microencapsulated vaccine for type A botulism using biodegradable PLGA microspheres.
• To assess the efficacy of a single-dose microencapsulated vaccine in a mouse model.

Main Methods:

• Water-soluble protein antigens were encapsulated in PLGA microspheres.
• In vitro release kinetics were measured using high-performance liquid chromatography.
• Vaccine efficacy was tested in C57BL/6J mice using an aerosol challenge with botulinum toxin.

Main Results:

• The microencapsulated vaccine was successfully prepared using a recombinant C fragment antigen.
• Enzyme-linked immunosorbent assay (ELISA) showed sustained antibody levels in immunized mice.
• In an aerosol challenge, 71% of vaccinated mice survived, while all control mice died.

Conclusions:

• Biodegradable polymer microspheres can effectively deliver vaccines and elicit protective immunity.
• Single-administration microencapsulated vaccines show promise for preventing botulism.
• This technology could enhance the efficiency and reduce the cost of routine immunization.